Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMEED for Resistant Corneal Ulcers
NCT06909149Completed
- Sponsor
- Tanta University
- Start
- May 2019
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of Amniotic membrane extract eye drops in corneal ulcer (2 arms), sponsored by Tanta University. Primary endpoint: Time of improvement of corneal ulcers at 7 weeks. Started May 2019; status: completed.
02
Drugs
Amniotic membrane extract eye drops
03
Conditions
corneal ulcer
Beyond the preview
Go deeper on NCT06909149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06909149.